Shots: Eli Lilly launches Reyvow C-V 50/100/200mg, indicated for the acute treatment of migraine with/without aura & will be available in US pharmacies in the next few days The efficacy […]readmore
Tags : Reyvow
Shots: The US FDA approval is based on P-III SAMURAI and SPARTAN, evaluated the safety and efficacy of Reyvow vs PBO for the acute treatment of migraine in adults, resulted […]readmore